Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

Wall, EC; Wu, M; Harvey, R; Kelly, G; Warchal, S; Sawyer, C; Daniels, R; Hobson, P; Hatipoglu, E; Ngai, Y; Hussain, S; Nicod, J; Goldstone, R; Ambrose, K; Hindmarsh, S; Beale, R; Riddell, A; Gamblin, S; Howell, M; Kassiotis, G; Libri, V; Williams, B; Swanton, C; Gandhi, S; Bauer, DLV

Bauer, DLV (corresponding author), Francis Crick Inst, London NW1 1AT, England.

LANCET, 2021; 397 (10292): 2331